{"name": "Spinomix",
 "permalink": "spinomix",
 "crunchbase_url": "http://www.crunchbase.com/company/spinomix",
 "homepage_url": "http://www.spinomix.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "contact@spinomix.com",
 "phone_number": "+41 21 693 92 50",
 "description": "",
 "created_at": "Thu Jan 10 04:49:29 UTC 2013",
 "updated_at": "Thu Jan 10 04:49:29 UTC 2013",
 "overview": "\u003Cp\u003ESpinomix SA is a spin-off company of the Swiss Federal Institute of Technology of Lausanne (EPFL) founded in November 2004. Our technology platform is based on a proprietary magnetic nanoparticles handling technology (MagPhase) in microfluidic environment (lab-on-chip). This technology offers cost efficient, reliable fully automated and miniaturized systems for various applications in life-science and in-vitro diagnostics. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       50],
      "assets/images/resized/0022/8972/228972v1-max-150x150.png"],
     [[250,
       84],
      "assets/images/resized/0022/8972/228972v1-max-250x250.png"],
     [[384,
       130],
      "assets/images/resized/0022/8972/228972v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$3M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.finsmes.com/2013/01/spinomix-closes-3m-series-equity-funding.html",
    "source_description": "Spinomix Closes $3M Series A Equity Funding",
    "raised_amount": 3000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 1,
    "funded_day": 9,
    "investments":
     [{"company":
        {"name": "Debiopharm Group",
         "permalink": "debiopharm",
         "image":
          {"available_sizes":
            [[[150,
               17],
              "assets/images/resized/0011/1746/111746v1-max-150x150.png"],
             [[250,
               29],
              "assets/images/resized/0011/1746/111746v1-max-250x250.png"],
             [[408,
               48],
              "assets/images/resized/0011/1746/111746v1-max-450x450.png"]],
           "attribution": null}},
       "financial_org": null,
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "PSE-B",
    "address2": "",
    "zip_code": "1015 ",
    "city": "Lausanne",
    "state_code": null,
    "country_code": "CHE",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}